Measure Name

Measure Category

PPRNet ID

CMS QID / QCDR ID

eCQM

MIPS Reportable?

Cervical Cancer Screening

Cancer Screening

5.1

309

CMS124

Yes

Breast cancer screening

Cancer Screening

5.2

112

CMS125

Yes

Colorectal cancer screening 

Cancer Screening

5.3

113

CMS130

Yes

Controlling high blood pressure (BP)

Cardiovascular Disease

2.3

236

CMS165

Yes

Concordance with ACC/AHA Cholesterol Guidelines for ASCVD Risk Reduction

Cardiovascular Disease

2.5

NA

NA

No

Antiplatelet Medication for High Risk Patients

Cardiovascular Disease

2.7

PPRNET8

NA

Yes

Patients with atrial fibrillation with current anti-platelet or oral anticoagulant Rx

Cardiovascular Disease

2.8

NA

NA

No

Heart Failure (HF): ACE Inhibitor or ARB Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Cardiovascular Disease

2.10

5

CMS135

Yes

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Cardiovascular Disease

2.11

8

CMS144

Yes

Patients screened for abdominal aortic aneurysm

Cardiovascular Disease

2.12

NA

NA

No

Screening for albuminuria in patients at risk for CKD (DM and/or HTN)

Chronic Kidney Disease

3.1

PPRNET32

NA

Yes

Monitoring for albuminuria in patients with CKD

Chronic Kidney Disease

3.2

NA

NA

No

Chronic Kidney Disease (CKD): Hemoglobin Monitoring

Chronic Kidney Disease

3.4

PPRNET14

NA

Yes

ACE Inhibitor or ARB Therapy in patients with HTN and Stage A2 or A3 Albuminuria

Chronic Kidney Disease

3.7

NA

NA

No

Screening for Type 2 Diabetes Mellitus

Diabetes Mellitus

1.1

PPRNET31

NA

Yes

Diabetes: Hemoglobin A1c control (< 8%) 

Diabetes Mellitus

1.4

NA

NA

No

Diabetes: Hemoglobin A1c (HbA1c) poor control (> 9%)

Diabetes Mellitus

1.5

1

CMS122

Yes

Diabetic Nephropathy

Diabetes Mellitus

1.6

119

CMS134

Yes

Diabetes: Eye exam

Diabetes Mellitus

1.8

117

CMS131

Yes

Tetanus

Immunizations

7.1

NA

NA

No

Influenza

Immunizations

7.2

110

CMS147

Yes

Pneumococcal Vaccination Status for Older Adults

Immunizations

7.3

111

CMS127

Yes

Pneumococcal: high risk patients 

Immunizations

7.4

NA

NA

No

Meningococcal

Immunizations

7.6

NA

NA

No

HPV

Immunizations

7.7

NA

NA

No

Zoster (shingles)

Immunizations

7.8

PPRNET34

NA

Yes

HIV screening

Infectious Disease Screening

6.1

NA

NA

No

Hepatitis C Screening

Infectious Disease Screening

6.2

400

NA

Yes

Use of high-risk medications in the elderly

Medication Safety

10.1

238

CMS156

Yes

Use of Benzodiazepines in the Elderly

Medication Safety

10.2

NA

NA

No

Appropriate dosages of H2 blockers in patients with decreased renal function

Medication Safety

10.3

NA

NA

No

Monitoring Serum Creatinine

Medication Safety

10.8

PPRNET29

NA

Yes

Treatment of Hypokalemia

Medication Safety

10.10

NA

NA

No

Glucose measured in past year in patients with Rx for any antipsychotic

Medication Safety

10.12

NA

NA

No

Patients with Dx of A-fib and Warfarin Rx with INR within the therapeutic range

Medication Safety

10.14

NA

NA

No

Avoiding Use of CNS Depressants in Patients on Long-Term Opioids

Medication Safety

10.15

PPRNET33

NA

Yes

Depression screening (adults)

Mental Health and Substance Abuse

8.1

NA

NA

No

Alcohol misuse: screening 

Mental Health and Substance Abuse

8.3

NA

NA

No

Patients with alcohol diagnosis or at-risk drinking with alcohol counseling in past year

Mental Health and Substance Abuse

8.4

NA

NA

No

Tobacco Use: Screening and cessation intervention

Mental Health and Substance Abuse

8.6

226

CMS138

Yes

PSA screening for prostate cancer in men age 70 years and older

Overuse

2

NA

NA

No

Vitamin D deficiency screening in patients age 18 years and older

Overuse

9

NA

NA

No

Appropriate Dosing of New Oral Anticoagulants (NOACs) in Patients with Renal Dysfunction 

Reducing ADEs

1.3

NA

NA

No

Renal Function Monitoring for New Oral Anticoagulants (NOACs)

Reducing ADEs

1.4

NA

NA

No

Avoiding Potential Overtreatment of High Risk Patients with Diabetes

Reducing ADEs

2.1

NA

NA

No

Avoiding Use of High Dose Opioid Therapy

Reducing ADEs

3.1

NA

NA

No

Use of appropriate medications for asthma 

Respiratory Disease

9.1

NA

NA

No

Appropriate treatment for adults with upper respiratory infection (URI)

Respiratory Disease

9.3

PPRNET24

NA

Yes

Chlamydia screening for women

Women’s Health Care

4.1

310

CMS153

Yes

Osteoporosis screening for women 

Women’s Health Care

4.2

39

NA

Yes

Chronic Kidney Disease (CKD): eGFR Monitoring

Chronic Kidney Disease



PPRNET13
NAYes